Exosomal secretion of α-synuclein as protective mechanism after upstream blockage of macroautophagy.
Exosomal secretion of α-synuclein as protective mechanism after upstream blockage of macroautophagy.
复制标题
DOI:
10.1038/s41419-018-0816-2
复制
发表时间:
2018-07-09
影响因子:
9
通讯作者:
Höglinger GU
中科院分区:
文献类型:
--
作者:
Fussi N;Höllerhage M;Chakroun T;Nykänen NP;Rösler TW;Koeglsperger T;Wurst W;Behrends C;Höglinger GU
Accumulation of pathological α-synuclein aggregates plays a major role in Parkinson’s disease. Macroautophagy is a mechanism to degrade intracellular protein aggregates by wrapping them into autophagosomes, followed by fusion with lysosomes. We had previously shown that pharmacological activation of macroautophagy protects against α-synuclein-induced toxicity in human neurons. Here, we hypothesized that inhibition of macroautophagy would aggravate α-synuclein-induced cell death. Unexpectedly, inhibition of autophagosome formation by silencing of ATG5 protected from α-synuclein-induced toxicity. Therefore, we studied alternative cellular mechanisms to compensate for the loss of macroautophagy. ATG5 silencing did not affect the ubiquitin–proteasome system, chaperone systems, chaperone-mediated autophagy, or the unfolded protein response. However, ATG5 silencing increased the secretion of α-synuclein via exosomes. Blocking exosomal secretion exacerbated α-synuclein-induced cell death. We conclude that exosomal secretion of α-synuclein is increased after impaired formation of autophagosomes to reduce the intracellular α-synuclein burden. This compensatory mechanism prevents α-synuclein-induced neuronal cell death.
登录
查看更多内容
DOI:
10.1073/pnas.1521230113
发表时间:
2016-02-23
影响因子:
11.1
作者:
Kowal, Joanna;Arras, Guillaume;Thery, Clotilde
通讯作者:
Thery, Clotilde
影响因子:
15.1
作者:
Danzer KM;Kranich LR;Ruf WP;Cagsal-Getkin O;Winslow AR;Zhu L;Vanderburg CR;McLean PJ
通讯作者:
McLean PJ
影响因子:
5.4
作者:
Klein, Christine;Westenberger, Ana
通讯作者:
Westenberger, Ana
影响因子:
30.8
作者:
Chang D;Nalls MA;Hallgrímsdóttir IB;Hunkapiller J;van der Brug M;Cai F;International Parkinson's Disease Genomics Consortium;23andMe Research Team;Kerchner GA;Ayalon G;Bingol B;Sheng M;Hinds D;Behrens TW;Singleton AB;Bhangale TR;Graham RR
通讯作者:
Graham RR
影响因子:
16.2
作者:
Bendor JT;Logan TP;Edwards RH
通讯作者:
Edwards RH